TABLE 2: Number of reported clinical dysfunctions among the dead subjects.
| Study | Number of deaths | Liver (%) | Respiratory (%) | Hematological (%) | Cardiovascular (%) | Renal (%) | Neurological (%) |
|---|---|---|---|---|---|---|---|
| Sarkar - 1967 | 2 | - | - | - | - | - | - |
| Ramful - 2007 | 1 | - | - | 1(100.0) | - | - | - |
| Rampal - 2007 | 6 | - | 1(16.7) | - | - | - | 6(100.0) |
| Renault - 2007 | 203 | - | - | - | - | - | - |
| Ernould - 2008 | 2 | - | - | - | 1(50.0) | - | 1(50.0) |
| Ganesan - 2008 | 1 | - | - | - | - | - | 1(100.0) |
| Lemant - 2008 | 16 | 2(12.5) | 4(25.0) | - | 3(18.8) | - | 4(25.0) |
| Robin - 2008 | 2 | - | - | - | 2(100.0) | - | 2(100.0) |
| Economopoulou - 2009 | 65 | 7(10.8) | 18(27.7) | - | 22(33.8) | 3(4.6) | 6(9.2) |
| Suryawanshi - 2009 | 3 | - | - | 1(33.3) | - | - | 2(66.7) |
| Tandale - 2009 | 26 | 5(19.2) | 5(19.2) | 1(3.8) | 5(19.2) | 15(57.7) | 20(76.9) |
| Tournebize - 2009 | 2 | - | - | - | - | - | 2(100.0) |
| Chua - 2010 | 1 | 1(100.0) | 1(100.0) | 1(100.0) | 1(100.0) | 1(100.0) | - |
| Kee - 2010 | 1 | - | 1(100.0) | 1(100.0) | - | 1(100.0) | - |
| Sam - 2010 | 1 | - | 1(100.0) | 1(100.0) | 1(100.0) | 1(100.0) | 1(100.0) |
| Gaüzère - 2011 | 21 | 3(14.3) | 7(33.3) | - | 7(33.3) | 1(4.8) | 3(14.3) |
| Gurav - 2012 | 3 | - | - | - | - | - | - |
| Hertz - 2012 | 5 | - | - | - | - | - | 1(20.0) |
| Garcia - 2014 | 2 | - | 1(50.0) | - | - | 2(100.0) | - |
| Hoz - 2015 | 3 | 1(33.3) | 3(100.0) | 2(66.7) | 2(66.7) | 3(100.0) | 1(33.3) |
| Shaikh - 2015 | 1 | - | - | - | - | - | 1(100.0) |
| Sharp - 2015 | 28 | - | - | - | - | - | - |
| Thiery - 2015 | 18 | - | - | - | - | - | - |
| Torres - 2015 | 3 | 3(100.0) | 3(100.0) | 2(66.7) | 3(100.0) | 3(100.0) | - |
| Viasus - 2015 | 1 | - | 1(100.0) | 1(100.0) | 1(100.0) | 1(100.0) | - |
| Betancur - 2016 | 1 | - | 1(100.0) | 1(100.0) | 1(100.0) | 1(100.0) | - |
| Carta - 2016 | 3 | - | - | - | - | - | - |
| Crosby - 2016 | 18 | - | - | - | - | - | - |
| Gérardin - 2016 | 7 | - | 1(14.3) | - | 5(71.4) | - | 7(100.0) |
| López - 2016 | 2 | - | - | - | - | - | - |
| Méndez-Domínguez - 2016 | 1 | 1(100.0) | 1(100.0) | 1(100.0) | 1(100.0) | 1(100.0) | 1(100.0) |
| Mercado - 2016 | 7 | - | - | 5(71.4) | 1(14.3) | 3(42.9) | - |
| Perti - 2016 | 6 | 2(33.3) | 1(16.7) | 5(83.3) | 2(33.3) | 3(50.0) | 4(66.7) |
| Rollé - 2016 | 14 | - | - | - | 12(85.7) | - | - |
| Rosso - 2016 | 1 | 1(100.0) | 1(100.0) | 1(100.0) | 1(100.0) | 1(100.0) | 1(100.0) |
| Balavoine - 2017 | 2 | - | 2(100.0) | - | - | - | 2(100.0) |
| Epelboin - 2017 | 1 | - | - | 1(100.0) | - | - | 1(100.0) |
| Evans-Gilbert - 2017 | 2 | - | 1(50.0) | 1(50.0) | 1(50.0) | 1(50.0) | 1(50.0) |
| Godaert - 2017 | 35 | - | - | - | - | - | - |
| Sá - 2017 | 4 | - | 4(100.0) | - | - | - | 4(100.0) |
| Gupta - 2018 | 22 | - | - | - | - | - | - |
| Koeltz - 2018 | 18 | - | - | - | 2(11.1) | - | - |
| Melo - 2018 | 22 | - | - | - | - | - | - |
| Mercado - 2018 | 13 | - | 6(46.2) | - | 8(61.5) | 6(46.2) | - |
| Silva Junior - 2018 | 383 | 19(5.0) | - | - | - | - | - |
| Gohel - 2019 | 3 | - | - | - | - | - | 3(100.0) |
| Lima Neto - 2019 | 169 | - | - | - | - | - | - |
| Pinto - 2019 | 269 | - | - | - | - | - | - |
| Rahman - 2019 | 3 | - | 1(33.3) | - | - | - | 2(66.7) |
| Ray - 2019 | 7 | - | - | - | - | - | - |
| Silva Junior - 2019 | 383 | - | - | - | - | - | - |
| Simião - 2019 | 245 | - | 29(11.8) | - | 13(5.3) | - | - |
“-“: not informed.